Pathophysiological aspects of hyperglycemia in children with meningococcal sepsis and septic shock: A prospective, observational cohort study

Critical Care

Volumn 15, Issue 1, 2011, Pages

  Verhoeven, Jennifer J ^a   den Brinker, Marieke ^b   Hokken Koelega, Anita C S ^a   Hazelzet, Jan A ^a   Joosten, Koen F M ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ANTIBIOTIC AGENT; C PEPTIDE; C REACTIVE PROTEIN; DEXAMETHASONE; ETOMIDATE; FATTY ACID; GLUCOSE; HYDROCORTISONE; INOTROPIC AGENT; INSULIN; INTERLEUKIN 6; LACTIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ABNORMAL LABORATORY RESULT; ADOLESCENT; AGE; ANTIBIOTIC THERAPY; ARTICLE; CHILD; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; CRITICALLY ILL PATIENT; FATTY ACID BLOOD LEVEL; FEMALE; FLUID THERAPY; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE INFUSION; GLUCOSE INTAKE; HOMEOSTASIS MODEL ASSESSMENT; HOSPITAL ADMISSION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERGLYCEMIA; HYPOGLYCEMIA; INFANT; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; INSULINEMIA; INTENSIVE CARE UNIT; LACTATE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MENINGOCOCCEMIA; OBSERVATIONAL STUDY; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SEPSIS; SEPTIC SHOCK; SINGLE DRUG DOSE; STEROID THERAPY; B LYMPHOCYTE; BACTEREMIA; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CRITICAL ILLNESS; DOUBLE BLIND PROCEDURE; MENINGOCOCCOSIS; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL;

B-LYMPHOCYTES; BACTEREMIA; CHILD; CHILD, PRESCHOOL; CRITICAL ILLNESS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERGLYCEMIA; INFANT; INSULIN RESISTANCE; INTENSIVE CARE UNITS, PEDIATRIC; MALE; MENINGOCOCCAL INFECTIONS; PROSPECTIVE STUDIES; SHOCK, SEPTIC;

EID: 79251543319     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc10006     Document Type: Article

References (42)

1. de Groof F, Joosten KF, Janssen JA, de Kleijn ED, Hazelzet JA, Hop WC, Uitterlinden P, van Doorn J, Hokken-Koelega AC. Acute stress response in children with meningococcal sepsis: important differences in the growth hormone/insulin-like growth factor I axis between nonsurvivors and survivors. J Clin Endocrinol Metab 2002, 87:3118-3124. 10.1210/jc.87.7.3118, 12107211.
2. den Brinker M, Joosten KF, Visser TJ, Hop WC, de Rijke YB, Hazelzet JA, Boonstra VH, Hokken-Koelega AC. Euthyroid sick syndrome in meningococcal sepsis: the impact of peripheral thyroid hormone metabolism and binding proteins. J Clin Endocrinol Metab 2005, 90:5613-5620. 10.1210/jc.2005-0888, 16076941.
3. Van den Berghe G. Endocrine changes in critically ill patients. Growth Horm IGF Res 1999, 9(Suppl A):77-81. 10.1016/S1096-6374(99)80015-X, 10429886.
4. den Brinker M, Joosten KF, Liem O, de Jong FH, Hop WC, Hazelzet JA, van Dijk M, Hokken-Koelega AC. Adrenal insufficiency in meningococcal sepsis: bioavailable cortisol levels and impact of interleukin-6 levels and intubation with etomidate on adrenal function and mortality. J Clin Endocrinol Metab 2005, 90:5110-5117. 10.1210/jc.2005-1107, 15985474.
5. Joosten KF, de Kleijn ED, Westerterp M, de Hoog M, Eijck FC, Hop WCJ, Voort EV, Hazelzet JA, Hokken-Koelega AC. Endocrine and metabolic responses in children with meningoccocal sepsis: striking differences between survivors and nonsurvivors. J Clin Endocrinol Metab 2000, 85:3746-3753. 10.1210/jc.85.10.3746, 11061534.
6. Hirshberg E, Larsen G, Van Duker H. Alterations in glucose homeostasis in the pediatric intensive care unit: hyperglycemia and glucose variability are associated with increased mortality and morbidity. Pediatr Crit Care Med 2008, 9:361-366. 10.1097/PCC.0b013e318172d401, 18496414.
7. Yung M, Wilkins B, Norton L, Slater A. Glucose control, organ failure, and mortality in pediatric intensive care. Pediatr Crit Care Med 2008, 9:147-152. 10.1097/PCC.0b013e3181668c22, 18477927.
8. Srinivasan V, Spinella PC, Drott HR, Roth CL, Helfaer MA, Nadkarni V. Association of timing, duration, and intensity of hyperglycemia with intensive care unit mortality in critically ill children. Pediatr Crit Care Med 2004, 5:329-336. 10.1097/01.PCC.0000128607.68261.7C, 15215001.
9. Cochran A, Scaife ER, Hansen KW, Downey EC. Hyperglycemia and outcomes from pediatric traumatic brain injury. J Trauma 2003, 55:1035-1038. 10.1097/01.TA.0000031175.96507.48, 14676647.
10. Wintergerst KA, Buckingham B, Gandrud L, Wong BJ, Kache S, Wilson DM. Association of hypoglycemia, hyperglycemia, and glucose variability with morbidity and death in the pediatric intensive care unit. Pediatrics 2006, 118:173-179. 10.1542/peds.2005-1819, 16818563.
11. Gore DC, Chinkes D, Heggers J, Herndon DN, Wolf SE, Desai M. Association of hyperglycemia with increased mortality after severe burn injury. J Trauma 2001, 51:540-544. 10.1097/00005373-200109000-00021, 11535907.
12. Branco RG, Garcia PC, Piva JP, Casartelli CH, Seibel V, Tasker RC. Glucose level and risk of mortality in pediatric septic shock. Pediatr Crit Care Med 2005, 6:470-472. 10.1097/01.PCC.0000161284.96739.3A, 15982437.
13. Yates AR, Dyke PC, Taeed R, Hoffman TM, Hayes J, Feltes TF, Cua CL. Hyperglycemia is a marker for poor outcome in the postoperative pediatric cardiac patient. Pediatr Crit Care Med 2006, 7:351-355. 10.1097/01.PCC.0000227755.96700.98, 16738506.
14. Faustino EV, Apkon M. Persistent hyperglycemia in critically ill children. J Pediatr 2005, 146:30-34. 10.1016/j.jpeds.2004.08.076, 15644818.
15. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 2004, 30:536-555. 10.1007/s00134-004-2398-y, 14997291.
16. Falcao G, Ulate K, Kouzekanani K, Bielefeld MR, Morales JM, Rotta AT. Impact of postoperative hyperglycemia following surgical repair of congenital cardiac defects. Pediatr Cardiol 2008, 29:628-636. 10.1007/s00246-007-9178-8, 18176772.
17. Buysse CM, Raat H, Hazelzet JA, Hulst JM, Cransberg K, Hop WC, Vermunt LC, Utens EM, Maliepaard M, Joosten KF. Long-term health status in childhood survivors of meningococcal septic shock. Arch Pediatr Adolesc Med 2008, 162:1036-1041. 10.1001/archpedi.162.11.1036, 18981351.
18. van Waardenburg DA, Jansen TC, Vos GD, Buurman WA. Hyperglycemia in children with meningococcal sepsis and septic shock: the relation between plasma levels of insulin and inflammatory mediators. J Clin Endocrinol Metab 2006, 91:3916-3921. 10.1210/jc.2006-0525, 16735484.
19. Day KM, Haub N, Betts H, Inwald DP. Hyperglycemia is associated with morbidity in critically ill children with meningococcal sepsis. Pediatr Crit Care Med 2008, 9:636-640. 10.1097/PCC.0b013e31818d350b, 18838926.
20. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979, 237:E214-223.
21. Legro RS, Finegood D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1998, 83:2694-2698. 10.1210/jc.83.8.2694, 9709933.
22. Saberi F, Heyland D, Lam M, Rapson D, Jeejeebhoy K. Prevalence, incidence, and clinical resolution of insulin resistance in critically ill patients: an observational study. JPEN J Parenter Enteral Nutr 2008, 32:227-235. 10.1177/0148607108316195, 18443133.
23. Basi S, Pupim LB, Simmons EM, Sezer MT, Shyr Y, Freedman S, Chertow GM, Mehta RL, Paganini E, Himmelfarb J, Ikizler TA. Insulin resistance in critically ill patients with acute renal failure. Am J Physiol Renal Physiol 2005, 289:F259-264. 10.1152/ajprenal.00002.2005, 15840772.
24. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004, 27:1487-1495. 10.2337/diacare.27.6.1487, 15161807.
25. Pollack MM, Ruttimann UE, Getson PR. Pediatric risk of mortality (PRISM) score. Crit Care Med 1988, 16:1110-1116. 10.1097/00003246-198811000-00006, 3048900.
26. Hatherill M, Tibby SM, Hilliard T, Turner C, Murdoch IA. Adrenal insufficiency in septic shock. Arch Dis Child 1999, 80:51-55. 10.1136/adc.80.1.51, 1717803, 10325759.
27. Hulst JM, van Goudoever JB, Zimmermann LJ, Hop WC, Buller HA, Tibboel D, Joosten KF. Adequate feeding and the usefulness of the respiratory quotient in critically ill children. Nutrition 2005, 21:192-198. 10.1016/j.nut.2004.05.020, 15723748.
28. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001, 345:1359-1367. 10.1056/NEJMoa011300, 11794168.
29. Soldin OP, Dahlin JR, Gresham EG, King J, Soldin SJ. IMMULITE 2000 age and sex-specific reference intervals for alpha fetoprotein, homocysteine, insulin, insulin-like growth factor-1, insulin-like growth factor binding protein-3, C-peptide, immunoglobulin E and intact parathyroid hormone. Clin Biochem 2008, 41:937-942. 10.1016/j.clinbiochem.2008.04.025, 18503765.
30. Parker MM, Hazelzet JA, Carcillo JA. Pediatric considerations. Crit Care Med 2004, 32:S591-594. 10.1097/01.CCM.0000145904.97821.0D, 15542968.
31. Hazelzet JA, van der Voort E, Lindemans J, ter Heerdt PG, Neijens HJ. Relation between cytokines and routine laboratory data in children with septic shock and purpura. Intensive Care Med 1994, 20:371-374. 10.1007/BF01720912, 7930034.
32. Marik PE, Raghavan M. Stress-hyperglycemia, insulin and immunomodulation in sepsis. Intensive Care Med 2004, 30:748-756. 10.1007/s00134-004-2167-y, 14991101.
33. Dimitriadis G, Leighton B, Parry-Billings M, Sasson S, Young M, Krause U, Bevan S, Piva T, Wegener G, Newsholme EA. Effects of glucocorticoid excess on the sensitivity of glucose transport and metabolism to insulin in rat skeletal muscle. Biochem J 1997, 321(Pt 3):707-712. 1218126, 9032457.
34. Loisa P, Parviainen I, Tenhunen J, Hovilehto S, Ruokonen E. Effect of mode of hydrocortisone administration on glycemic control in patients with septic shock: a prospective randomized trial. Crit Care 2007, 11:R21. 10.1186/cc5696, 2151907, 17306016.
35. Rosmarin DK, Wardlaw GM, Mirtallo J. Hyperglycemia associated with high, continuous infusion rates of total parenteral nutrition dextrose. Nutr Clin Pract 1996, 11:151-156. 10.1177/0115426596011004151, 9070016.
36. Ahrens CL, Barletta JF, Kanji S, Tyburski JG, Wilson RF, Janisse JJ, Devlin JW. Effect of low-calorie parenteral nutrition on the incidence and severity of hyperglycemia in surgical patients: a randomized, controlled trial. Crit Care Med 2005, 33:2507-2512. 10.1097/01.CCM.0000186746.64572.8A, 16276174.
37. Sheridan RL, Yu YM, Prelack K, Young VR, Burke JF, Tompkins RG. Maximal parenteral glucose oxidation in hypermetabolic young children: a stable isotope study. JPEN J Parenter Enteral Nutr 1998, 22:212-216. 10.1177/0148607198022004212, 9661121.
38. Joosten KF, Verhoeven JJ, Hazelzet JA. Energy expenditure and substrate utilization in mechanically ventilated children. Nutrition 1999, 15:444-448. 10.1016/S0899-9007(99)00081-7, 10378198.
39. Verbruggen SC, Joosten KF, Castillo L, van Goudoever JB. Insulin therapy in the pediatric intensive care unit. Clin Nutr 2007, 26:677-690. 10.1016/j.clnu.2007.08.012, 17950500.
40. Preissig CM, Rigby MR. Hyperglycaemia results from beta-cell dysfunction in critically ill children with respiratory and cardiovascular failure: a prospective observational study. Crit Care 2009, 13:R27. 10.1186/cc7732, 2688145, 19245691.
41. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R. Intensive insulin therapy in the medical ICU. N Engl J Med 2006, 354:449-461. 10.1056/NEJMoa052521, 16452557.
42. Cobelli C, Toffolo GM, Man CD, Campioni M, Denti P, Caumo A, Butler P, Rizza R. Assessment of β-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests. Am J Physiol Endocrinol Metab 2007, 293:E1-E15. 10.1152/ajpendo.00421.2006, 17341552.